Product Information
TEMOZOLOMIDE 180 MG CAPSULE is a generic product labeled by Devatis Inc., priced at $21.4132 per EA under NDC 73043001505. Its NADAC has been published 36 times since Jul 9, 2025.
Strength
180 mg/1
Manufacturer
Devatis Inc.NDC
73043001505
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/9/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207658On Market Since
4/28/2017
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 180 MG CAPSULE has been published 36 times since Jul 9, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.4132 per EA |
|---|---|
| All-time high | $21.4132 (Mar 11, 2026) |
| All-time low | $21.4132 (Jul 9, 2025) |
| 52-week high | $21.4132 |
| 52-week low | $21.4132 |
| Median price | $21.4132 |
| Average price | $21.4132 |
| Largest weekly change | 0.0% (Jul 16, 2025) |
| Weeks tracked | 36 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 180 MG CAPSULE, manufactured by Devatis Inc., is $21.4132 per EA (NDC 73043001505), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 180 MG CAPSULE?
Since Jul 9, 2025, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has ranged from a low of $21.4132 (Jul 9, 2025) to a high of $21.4132 (Mar 11, 2026), with a median of $21.4132 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 180 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 180 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 180 MG CAPSULE?
TEMOZOLOMIDE 180 MG CAPSULE (NDC 73043001505) is labeled by Devatis Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification